Skip Navigation

Journal of Tropical Pediatrics 1990 36(2):56-62; doi:10.1093/tropej/36.2.56
© 1990 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by El-Hazmi, M. A. F.
Right arrow Articles by Warsy, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Hazmi, M. A. F.
Right arrow Articles by Warsy, A. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


research-article

Symptom-free Intervals in Sicklers: Does Pneumococcal Vaccination and Penicillin Prophylaxis Have a Role?

M. A. F. El-Hazmi, BSc(Hons), MB, BChir, PhD(Cantab), MRCPath*, H. M. Bahakim, MD*, M. A. Babikar, MRCP* {dagger}, A. M. Al-Swailem** and A. S. Warsy, PhD***

*College of Medicine & King Khalid Hospital, King Sand University Riyadh, Saudi Arabia
**Ministry of Health Riyadh, Saudi Arabia
***Department of Biochemistry, Centre for Science & Medical Studies for Girls, College of Science, King Saud University Riyadh, Saudi Arabia

Address for Correspondence: Professor Mohsen A. F. ElHazmi, Medical Biochemistry Department, College of Medicine & King Khalid Hospital, Po Box 2925, Riyadh 11461, Saudi Arabia.

To investigate the combined effect of pneumococcal vaccination and penicillin prophylaxis on the progress of sickle cell disease, two goups of sickle cell disease patients, presenting with severe clinical manifestations of the disease were selected as cohorts. One group was vaccinated with the polyvalent pneumococcal vaccine and given penicillin prophylaxis, while the other group was not given the vaccine and penicillin. Clinical manifestations, frequency of hospitalization, crises and blood transfusion requirements, haematological parameters, and differential counts were recorded for each patient in the two groups. The ‘severity index’ of the sickle cell disease was calculated for each patient. No significant differences wre encountered in the values of the haematological parameters except for the whjite cell count which was significantly higher in the non-vaccinated group. However, the frequency of hospitalization, crisis, and blood transfusion were significantly higher in the non-vaccinated group compared to the vaccinated group. Clinical symptoms frequently associated with severe sickle cell disease, were also encountered at a higher frequency in the non-vaccinated group. These results show that pneumococcal vaccination and penicillin prophylaxis increase the crisis-free interval in sickle cell disease patients, and play a significant role in decreasing the morbidity associated with sickle cell disease.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.